RVLPQ (RVL Pharmaceuticals) Change In Inventory: $-0.83 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RVLPQ RVL Pharmaceuticals PLC RVLPQ
12 GF Score
Price $0.00
View Full Analysis

What is RVL Pharmaceuticals Change In Inventory?

RVL Pharmaceuticals RVLPQ -90.00% 12 Change In Inventory is $-0.83 Mil as of Jun. 2023. GuruFocus rates RVLPQ with a GF Score™ of 12/100.

RVL Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2023 was $-1.14 Mil. It means RVL Pharmaceuticals's inventory increased by $1.14 Mil from Mar. 2023 to Jun. 2023 .

RVL Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2022 was $0.05 Mil. It means RVL Pharmaceuticals's inventory declined by $0.05 Mil from Dec. 2021 to Dec. 2022 .

RVL Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2023 was $1.36 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. RVL Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2023 was 36.79.

Inventory Turnover measures how fast the company turns over its inventory within a year. RVL Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2023 was 2.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. RVL Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.09.

RVL Pharmaceuticals  (OTCPK:RVLPQ) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

RVL Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0.7845/1.946*365 / 4
=36.79

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

RVL Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.946 / 0.7845
=2.48

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

RVL Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0.7845 / 8.258
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RVL Pharmaceuticals Change In Inventory Related Terms

RVL Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for RVL Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RVL Pharmaceuticals Change In Inventory Chart

RVL Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Inventory
Get a 7-Day Free Trial -7.44 3.08 3.37 2.60 0.05

RVL Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 -0.09 -0.16 0.57 -1.14
RVLPQ
12GF Score
RVL Pharmaceuticals PLC RVLPQ
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RVL Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-0.83 Mil mean?
RVL Pharmaceuticals (RVLPQ) has a Change In Inventory of $-0.83 Mil as of Jun. 2023. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for RVL Pharmaceuticals and its competitors.
Is RVL Pharmaceuticals' Change In Inventory too high?
RVL Pharmaceuticals' current Change In Inventory is $-0.83 Mil. Overall, RVL Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does RVL Pharmaceuticals' Change In Inventory compare to SNPX and THAR?
RVL Pharmaceuticals' Change In Inventory of $-0.83 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for RVL Pharmaceuticals and its competitors. RVL Pharmaceuticals's current Change In Inventory is $-0.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RVL Pharmaceuticals stock overvalued right now?
RVL Pharmaceuticals (RVLPQ) has a current Change In Inventory of $-0.83 Mil. The current Change In Inventory is $-0.83 Mil. RVL Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For RVL Pharmaceuticals (RVLPQ), the current Change In Inventory is $-0.83 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RVL Pharmaceuticals Business Description

Address 400 Crossing Boulevard, Bridgewater, NJ, USA, 08807
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
12GF Score

Get the complete analysis for RVLPQ

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price